Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Quamed AB
AB
Active
Org 5593704108
Medical specialists activities · NACE 8622
Est. 2022
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 850K
-49% vs 2024
EBITDA margin
88.4%
+44% vs 2024
Equity ratio
84.4%
Financial strength
Net profit 2025
SEK 679K
+64% vs 2024
EBITDA — year on year
SEK millions
1M
1M
1M
0M
0M
0M
2023
1M
+100%
2024
1M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 850K
-49%
EBITDA
SEK 751K
+44%
Net profit
SEK 679K
+64%
Total assets
SEK 923K
+26%
Equity
SEK 779K
+77%
Employees
1
—
Company information
Legal name
Quamed AB
Org number
5593704108
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
14 mars 2022
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva verksamhet inom hälsobranschen samt därmed förenlig verksamhet.
Contact
Address
Email
taye.demeke.td@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Göteborg
All Sweden companies
Revenue
SEK millions
0M
1M
1M
2M
2M
0M
2023
2M
2024
1M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2023
1M
2024
1M
2025
Income statement
SEK thousands
Item
2023
2024
2025
Revenue
467
1 663
850
Staff expenses
−228
−1 095
−84
EBITDA
228
522
751
Depreciation & amort.
—
—
—
EBIT
228
522
751
Net financials
—
−0
−3
Profit before tax
228
522
748
Tax
−47
−108
−69
Net profit
181
414
679
Balance sheet
SEK thousands
Item
2023
2024
2025
Total assets
381
736
923
Equity
206
441
779
Long-term debt
—
—
—
Short-term debt
175
295
144
Total debt
175
295
144
Financial ratios
5-year trend
EBITDA margin
88.4%
This company
15.8%
Market median
+459% vs market
2023
2025
Equity ratio
84.4%
This company
38.2%
Market median
+121% vs market
2023
2025
Return on equity
87.1%
This company
18.4%
Market median
+373% vs market
2023
2025
Net profit margin
79.9%
This company
8.1%
Market median
+886% vs market
2023
2025
Asset turnover
0.92×
This company
1.12×
Market median
+18% vs market
2023
2025
Debt / equity
0.18×
This company
0.62×
Market median
+71% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-03-14 – 2023-06-30
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (2)
TD
Taye Demeke
Chief Executive Officer
Chief Executive Officer
2022
AT
Amasiah Taye
Deputy Chief Executive Officer
Deputy Chief Executive Officer
2022
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Quamed AB also hold positions in
0
other companies.
Person
Role here
Other companies
Taye Demeke
Chief Executive Officer
0 companies
Amasiah Taye
Deputy Chief Executive Officer
0 companies